trending Market Intelligence /marketintelligence/en/news-insights/trending/jLIBSNBjW9Yr06jvLq2REw2 content esgSubNav
In This List

Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Corindus Vascular Robotics Inc. stockholders approved Siemens Healthineers AG's $1.1 billion acquisition of the company.

The Waltham, Mass.-based maker of robotic-assisted systems said stockholders also approved certain compensation to be paid to some of its executives in connection with the merger.

Germany's Siemens Healthineers announced the acquisition in August, agreeing to pay in cash $4.28 apiece for Corindus common stock and $85.60 apiece for series A and series A-1 preferred stocks.

Corindus will be delisted from the NYSE American once the transaction closes Oct. 29.

Citigroup Global Markets Inc. and Cadwalader Wickersham & Taft LLP advised Corindus on the deal.